ALTHX.PA Gross Margin

The Gross Margin of Theranexus SA (ALTHX.PA) is -217.60%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ALTHX.PA Gross Margin - Historical Value

Date	Value
2023-12-31	-217.60%

ALTHX.PA Gross Margin - Peers Comparison

Ticker	Name	Value
ADVIC.PA	Advicenne SA	-49723.60%
HOTH	Hoth Therapeutics Inc	7775.20%
KLAR.ST	Klaria Pharma Holding AB (publ)	100.00%
BETR.CN	BetterLife Pharma Inc	7775.20%
SKIN.SW	Cassiopea SpA	100.00%
IMM.L	ImmuPharma PLC	100.00%
LIPI.ST	Lipidor AB	-82.31%
AVCN.TO	Avicanna Inc	45.38%
CNBX	CNBX Pharmaceuticals Inc	100.00%
FUM.L	Futura Medical PLC	69.58%
NFX.L	Nuformix PLC	96.60%
REDX.L	Redx Pharma PLC	88.82%
RLS.ST	RLS Global AB	-34.31%
TRVI	Trevi Therapeutics Inc	7775.20%
BOI.PA	Boiron SA	72.60%
IPN.PA	Ipsen SA	82.69%
MEDCL.PA	Medincell SA	74.92%
STX.L	Shield Therapeutics PLC	30.78%
ALZCUR.ST	AlzeCure Pharma AB	7775.20%
ANNX.ST	Annexin Pharmaceuticals AB (publ)	7775.20%
ASAP.ST	Asarina Pharma AB (publ)	7775.20%
SAR.L	Sareum Holdings PLC	-41.33%
AB.PA	AB Science SA	60.52%
ACER	Acer Therapeutics Inc	100.00%
ADIL	Adial Pharmaceuticals Inc	7775.20%
GABA.ST	Gabather AB	7775.20%
NGEN.V	NervGen Pharma Corp	7775.20%
VETO.PA	Vetoquinol SA	61.27%
HRTIS.HE	Herantis Pharma Oyj	-7.12%
NWRN.SW	Newron Pharmaceuticals SpA	98.26%
SAN.PA	Sanofi SA	70.18%
VIRP.PA	Virbac SA	67.10%